Founded in 1982, Baupost Group is one of the largest hedge funds in the world and has generated an average annual return of 19% since its inception.......
(read more)August 22 - Hedge Funds, News - Comments
In its recent 13F filing with the U.S. Securities and Exchange Commission, Nancy Havens-Hasty’s Havens Advisors has disclosed its long equity positions......
(read more)July 23 - Hedge Funds, News - Comments
Baupost up nearly $1 billion on Merck-Idenix deal (CNBC) Not bad for a single trade: Baupost Group appears to have made nearly $1 billion on just one......
(read more)June 9 - Hedge Funds - Comments
Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings. The hedge fund has invested $267.02 million in equity portfolio......
(read more)February 14 - Hedge Funds, News - Comments
Baupost Group, managed by Seth Klarman, in a new 13F filing, reported the holdings from its equity portfolio for the fourth quarter. The value of its......
(read more)February 14 - Hedge Funds, News - Comments
Baupost Group, a fund managed by Seth Klarman, is a large shareholder of Idenix Pharmaceuticals Inc (NASDAQ:IDIX). The fund disclosed, in a new filing......
(read more)February 5 - Hedge Funds, News - Comments
Sony drags down Loeb’s October returns (NYPost) Hedgie Dan Loeb’s long winning streak continued in October — although a 20 percent drop in his high......
(read more)November 6 - Hedge Funds, News - Comments
Seth Klarman’s Baupost Group, one of the largest hedge funds in the world, reported in a new filing with the SEC increasing its exposure at Idenix......
(read more)November 1 - Hedge Funds, News - Comments
According to a recent Bloomberg report, Gilead Sciences, Inc. (NASDAQ:GILD) has chosen the legal route to protect sofosbuvir — its candidate for......
(read more)September 11 - News - Comments
Is it smart to be bullish on Dyax Corp. (NASDAQ:DYAX)? Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment......
(read more)September 6 - News - Comments
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age. Although there are over 8,000......
(read more)September 3 - News - Comments
Is it smart to be bullish on Sequenom, Inc. (NASDAQ:SQNM)? If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles......
(read more)August 30 - News - Comments
Should investors bullish on QLT Inc. (USA) (NASDAQ:QLTI) consider the following data? In the financial world, there are many indicators shareholders......
(read more)August 30 - News - Comments
The biotech industry is a marvel among traders and investors because it can double your investment, or halve it, based on a single clinical study. Millions......
(read more)August 25 - News - Comments
Biotech’s the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling......
(read more)July 22 - News - Comments
The biotech industry is a cutthroat one, with companies constantly racing to get new treatments approved by the FDA ahead of their rivals. In my previous......
(read more)July 22 - News - Comments
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) just can’t catch a break. The company is down nearly 30% today after announcing that the Food and Drug......
(read more)June 28 - News - Comments
What’s the best way to choose the biotech winner and loser of the past week? The easiest route would involve the companies with the biggest share price......
(read more)June 25 - News - Comments
The overall markets experienced the biggest one-day losses in quite a while this week. But those drops were pocket change compared with these horrendous......
(read more)June 24 - News - Comments
Netflix, Inc. (NASDAQ:NFLX) had a good week. It started when the company teamed up with Dreamworks Animation Skg Inc (NASDAQ:DWA) to expand their relationship......
(read more)June 24 - News - Comments
Are investors hitting the brakes on biotech? The biotech sector’s one of the most boom-or-bust areas for investors, where fortunes can be won or......
(read more)June 24 - News - Comments
Dyax Corp. (NASDAQ:DYAX) has seen an increase in support from the world’s most elite money managers in recent months. In the eyes of most traders......
(read more)June 10 - News - Comments
Small biotech companies have great investment potential if you can identify them properly. A small biotech with a differentiated treatment approach and......
(read more)April 24 - News - Comments
Is Dyax Corp. (NASDAQ:DYAX) the right investment to pursue these days? The best stock pickers are taking a bullish view. The number of long hedge fund......
(read more)April 1 - News - Comments
Have you checked your 401(k) or IRA balance lately? If you’re like many people, the numbers brought forth a smile, with the major indexes hitting......
(read more)March 30 - News - Comments
Is Idenix Pharmaceuticals Inc (NASDAQ:IDIX) the right investment to pursue these days? The smart money is in an optimistic mood. The number of long hedge......
(read more)March 27 - News - Comments
Gilead Sciences, Inc. (NASDAQ:GILD)‘ sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir‘s simeprevir are a match made in heaven......
(read more)March 5 - News - Comments
In the world of biotech stocks a lot of companies are starting to incorporate Hepatitis C treatments into their pipelines. Hepatitis C is starting to......
(read more)February 25 - News - Comments
The Motley Fool’s readers have spoken, and I have heeded your cries. After months of pointing out CEO gaffes and faux pas, I’ve decided to......
(read more)February 20 - News - Comments
Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......
(read more)February 15 - News - Comments
Stocks are rolling along unchallenged, surging to highs not seen since 2007. Investors are partying like it’s before the recession, but with many......
(read more)February 13 - News - Comments
Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? One......
(read more)February 11 - News - Comments
